0001209191-20-061940.txt : 20201207
0001209191-20-061940.hdr.sgml : 20201207
20201207162233
ACCESSION NUMBER: 0001209191-20-061940
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201204
FILED AS OF DATE: 20201207
DATE AS OF CHANGE: 20201207
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hagan Joseph P
CENTRAL INDEX KEY: 0001465278
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35670
FILM NUMBER: 201372980
MAIL ADDRESS:
STREET 1: 3344 N. TORREY PINES COURT, SUITE 200
CITY: LA JOLLA
STATE: CA
ZIP: 92037
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Regulus Therapeutics Inc.
CENTRAL INDEX KEY: 0001505512
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 264738379
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10628 SCIENCE CENTER DRIVE
STREET 2: SUITE 225
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-202-6300
MAIL ADDRESS:
STREET 1: 10628 SCIENCE CENTER DRIVE
STREET 2: SUITE 225
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-12-04
0
0001505512
Regulus Therapeutics Inc.
RGLS
0001465278
Hagan Joseph P
C/O REGULUS THERAPEUTICS INC.
10628 SCIENCE CENTER DR., #225
SAN DIEGO
CA
92121
1
1
0
0
President and CEO
Common Stock
2020-12-04
4
A
0
39680
0.6301
A
225674
I
Securities purchased through an affiliated investment entity
Common Stock Purchase Warrant (Right to Buy)
0.7464
2020-12-04
4
A
0
29760
0.125
A
2020-12-04
2025-12-04
Common Stock
29760
29760
I
Securities purchased through an affiliated investment entity
/s/ Christopher Aker, Attorney in Fact
2020-12-07